Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC
Retrieved on:
Monday, January 17, 2022
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, MSD, Doctor of Philosophy, Research, East Anglia, CMC, D, Cass Business School, MBA, Chemistry, CEO, Process, Solution, GMP, CGT, Industry, CGMP, Control, Process chemistry, API, Drug discovery, Senior, University of East Anglia, Management, Fine chemical, Hoddesdon
Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (Pharmaron) today announced the appointment of Dr. Antony (Tony) Davies as Senior Vice President, UK CMC, effective January 10, 2022.
Key Points:
- Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (Pharmaron) today announced the appointment of Dr. Antony (Tony) Davies as Senior Vice President, UK CMC, effective January 10, 2022.
- The UK Chemistry, Manufacturing and Control (CMC) business includes operations in Hoddesdon and Cramlington, UK.
- Tony has been Senior Vice President, Process R&D, since 2019, having been promoted from Vice President, Process Chemistry, a post he held since Pharmaron acquired the MSD Hoddesdon site in 2016.
- The UK CMC business currently includes operations in Hoddesdon and Cramlington, UK.